相关实验视频

Updated: Jun 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

新型机器学习预测工具,用于冠状腺癌患者的整体生存期:基于递归分区分析

Xiong-Gang Yang^1,2, Shan-Shan Yang³, Yi Bao^1,2

¹Department of Orthopedics, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.

Cancer medicine

|August 10, 2024

概括

一个使用递归分区分析 (RPA) 的新工具预测了冠状骨肉瘤 (CHS) 患者的整体存活率. 该方法识别了关键预测因素,并提供了个性化的生存估计,以改善骨癌治疗的临床决策.

科学领域:

在瘤学瘤学.
生物统计学生物统计学
医疗信息学医疗信息学

背景情况:

软骨肉瘤 (CHS) 是一种具有挑战性的骨恶性瘤,结果各不相同.
现有的预测工具缺乏整合多个因素来进行个性化预测.
需要先进的仪器来估计CHS患者的整体存活率.

研究的目的:

使用递归分区分析 (RPA) 开发一种用于冠状腺癌 (CHS) 的新型预测工具.
为了提高个人CHS患者的整体存活率估计的准确性.
创建一个用户友好的临床决策支持应用程序.

主要方法:

从SEER数据库 (2000-2018) 中分析人口,临床和治疗数据.
开发决策树模型,使用C5.0算法在多个时间点进行生存预测.
使用精度,ROC曲线和AUC评估模型性能.

主要成果:

确定了关键预测因素:瘤组织学,手术,年龄,内脏转移,化疗,等级和性别.
决策树模型显示出高准确度 (82-89%) 和差异化能力 (AUC 0.80-0.89).
为简化生存预测开发了一个交互式基于Web的应用程序.

结论:

递归分区分析 (RPA) 有效地创建了一个个性化的生存预测工具,用于冠状骨肉瘤 (CHS).
开发的决策树模型表现出强大的预测性能.
互动应用程序有助于临床医生在CHS患者管理方面的决策.

关键词:

在C5.0算法中,C5.0算法这种疾病是chondrosarcoma.决策树模型决策树模型总体存活率总体存活率递归分区分析.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...